Best Practice Using Rocuronium and Reversal With Neostigmine or Sugammadex
Clinical trial NCT03543826 · COMPLETED
Trial details
- NCT number
- NCT03543826
- Sponsor
- University of Washington
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-21
- Primary completion
- 2018-11-26
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.